Alterrnative Mental Health News #59

[Guest guest]

" EZine " <ezine

Alterrnative Mental Health News #59

Fri, 15 Jul 2005 06:24:15 -0400 (EDT)

 

 

 

Issue 59, July 2005

 

The ALTERNATIVE MENTAL HEALTH News

 

Only in America of 2005 would you find a celebrity like Tom Cruise

having to defend the idea that non-drug solutions like vitamins and

exercise are a healthier choice than antidepressants.

 

Unless you were on Mars this past month, you heard the media bashing

Cruise for suggesting that there are healthier alternatives for mental

problems than psychiatric drugs. Some reporters were positively

indignant, dragging out commentaries from the American Psychiatric

Association that Cruise's views were irresponsible and completely out

of synch with the rest of the modern world.

 

Well, not quite, guys.

 

Agreeing with Cruise would be...oh, about half a billion Chinese who

still rely on traditional Chinese medicine, practiced for thousands of

years, and would never dream of taking an anti-depressant. I guess we

should toss in those in Japan, Korea, and other Asian nations who feel

the same.

 

Then there are all the traditional healers in developing nations from

Colombia to Nigeria to the Sultanate of Oman, who have been treating

mental problems without drugs for centuries. Did you know that

schizophrenics recover far faster in Nigeria than in the US? The UN

was so shocked to discover this that they studied it twice and got the

same results.

 

And I suppose we should throw in the millions in India who, instead of

drugs, use Ayurvedic medicine. They, too, apparently join Cruise in

the dunce's corner, according to the media.

 

And, of course, there are the fundamentalist Christians who believe

that mind-altering drugs should not be used as a " crutch " (remember

that use of the word?), there are the Christian Scientists who use no

drugs, and there are the Scientologists (including Cruise).

 

And while we're at it, let's include about a few million American

grandparents who remember a time when you didn't drug kids for

misbehaving or adults who were depressed but you addressed the matters

with common sense solutions.

 

And gee whiz, I guess we'll have to include the thousands of

alternative physicians, holistic psychiatrists, nutritional

psychologists, naturopathic doctors, homeopaths, chiropractors,

nutritionists, herbalists, and other healers, in the U.S. alone, and

all of their faithful patients.

 

Supreme arrogance is when you believe that if you don't know about it,

it must not be important. With this Cruise controversy, the media and

the psychiatric community have really laid bare their ignorance of

healthy alternatives in mental health and their arrogance in believing

they have nothing to learn about alternatives.

 

Let's hope this fracas has brought a little more attention to the

healthy options that are out there.

SAFE HARBOR PRESIDENT DAN STRADFORD STEPPING DOWN

 

Safe Harbor founder and president Dan Stradford has announced he will

be resigning in the next few months. His reason for stepping down is

that demands on his time have become too great and he is having to

make changes to accommodate this.

 

" This has been a very difficult decision for me to make, one I have

delayed for some time now, " Dan said. " But it is a necessary one.

 

" I am hoping someone will be interested in taking the reins of Safe

Harbor and carrying it forward from this point. It is not a paid

position. I have always done it as a labor of love. Outside of being a

father, it is the most gratifying work I have ever done. And I will

continue to assist as a consultant and speaker. "

 

Anyone interested in replacing Dan should contact the Safe Harbor

office at SafeHarborProj or (626) 791-7868.

NON-PHARMA EAST CONFERENCE POSTPONED TO SEPTEMBER

 

Safe Harbor has learned that the Non-Pharma East Conference,

originally scheduled for late July 2005 has been moved to early

September (the exact dates have not been released). The conference is

being hosted by V.O.I.C.E. of New York State, a Safe Harbor affiliate.

 

For more information, contact Fred Bauer, president of V.O.I.C.E., at

admin.

HELP UPDATE SAFE HARBOR!

 

If you have a new postal mailing or e-mail address, please send it to

wendy, so that we can keep our databases

current. We will be sending out the information on this year's medical

conference (NP4) soon, so don't miss out. Send us your updates. Thanks.

NON-PHARMA IV, SAFE HARBOR'S FOURTH ANNUAL MEDICAL CONFERENCE,

AVAILABLE ON CD

 

On June 4 and 5, 2005, Safe Harbor presented its Fourth Annual Medical

Conference, Non-Pharma IV, at the Glendale Hilton in Glendale,

California. The conference was an outstanding success, and the

lectures are available on CD. We are offering the complete CD set with

syllabus at the special price of $235.00 plus $10.00 shipping and

handling (U.S. and Canada only; please contact us for shipping amount

on international orders) for the entire month of July! (California

residents, please add 8.25% tax of $19.39.) This special price is good

until July 31, 2005, at midnight. Special price good only on complete

CD sets. Single CDs available at regular prices. Please allow 2-4

weeks for delivery.

 

With a dozen hour-long lectures...

 

* Find out about safe non-drug treatments for postpartum depression

from Nancy Lins, N.D. * Hear the exciting and rousing talk about the

neurotoxicity of fluoride by David Kennedy, D.D.S. * Find out how

integrative medicine approaches can help depression and anxiety from

Joseph Sciabbarrasi, M.D. * Learn how infection and xenobiotics affect

mental health from Aristo Vajdani, Ph.D. * Learn more about the dental

connection in Is It Mental or Is It Dental? Part II by Raymond

Silkman, D.D.S. * Find out what the Crazy Makers in our food supply

are doing to our mental health and what you can do about it in a

humorous and powerful talk from famed nutritionist and author Carol

Simontacchi, M.S., C.C.N. * Hear the emotional and heartfelt success

stories from people who have recovered on the Recovery Panel * And more!

 

To order online, please visit

http://alternativementalhealth.com/lectures/pharma4.htm

 

You may also order by phone at 626-791-7868 or send a check or money

order to Safe Harbor, 787 W. Woodbury Rd., #2, Altadena, CA 91001.

AFTER " CODEX " MEETING, MAJOR VICTORY FOR ALLIANCE FOR NATURAL HEALTH

 

On July 12, 2005, the Alliance for Natural Health (ANH) succeeded in

getting a ruling from the European Court of Justice that requires the

controversial EU Food Supplements Directive to be very sharply

circumscribed in its application.

 

Briefly, vitamins and minerals found in human diet are NOT to be

banned. The ECJ found the " Codex Alimentarius " Food Supplements

Directive valid, but with a clarified and sharply restricted scope of

application:

 

* The Court has accepted and addressed key arguments uniquely put

by the Alliance for Natural Health.

* The ban on non-positive [not proven safe] list of vitamins and

minerals does not apply at all to vitamins and minerals normally found

in or consumed as part of the diet which therefore are not banned as

of 1 August 2005.

* Where the Food Supplements Directive does apply (which is to

vitamins and minerals derived from " chemical substances " i.e. not

naturally derived) an application to have a substance included on the

positive list may be refused by the competent authorities only on the

basis of a full assessment of the risk posed to public health by the

substance, established on the basis of the most reliable scientific

data available and the most recent results of international research.

 

Two main concerns motivated the challenge to the Food Supplements

Directive.

 

The first was that the Directive appeared to ban food supplements

obtained from natural sources forming part of the normal diet, about

which there was no reason to believe that there was any risk to

health. ANH maintained that that was inconsistent with certain

recitals in the preamble to the Directive, which had not been followed

through when the lists of permitted food supplements were compiled. On

that point, none of the opposing parties disputed the fact that the

Directive did indeed prohibit naturally-sourced food supplements,

although there had been some confusion about this among different

Government agencies in the UK.

 

The second point was the absence of adequate procedures for obtaining

amendments to the positive lists: the Advocate General described the

procedures as having the " transparency of a black box " and considered

that the Directive should be annulled for that reason alone.

 

The Court has upheld the validity of the Directive but, in doing so,

has addressed ANH's main concerns.

 

On the first point, the Court has stated that the Directive is to be

interpreted as applying only to " food supplements containing vitamins

and/or minerals derived from a manufacturing process using 'chemical

substances,' " not other food supplements (paragraph 63 of the judgment).

 

On the second point, while criticizing some aspects of the drafting of

the Directive (see paragraph 92 of the judgment), the Court had

recourse to the general principles of EC law and has identified the

main characteristics of the procedures that must be followed (thus

clearing up an obscurity in the Directive) and has effectively laid

down the basic criteria to be applied when operating those procedures

and deciding whether or not to amend the positive lists. (paragraphs

72-92 of the judgment).

 

In doing that, the Court has followed the well-established principle

that legislation is, wherever possible, to be interpreted so as to

avoid it having to be annulled. The fact that the Court was able to

satisfy ANH's main concerns by that means without invalidating the

Directive (which has undoubtedly some good features) means that the

judgment has produced a win-win situation.

 

This is great news for the tens of millions of consumers across Europe

who take vitamin and mineral supplements – and the thousands of

practitioners, retailers and manufacturers whose small businesses rely

upon them. Well done David. Bad luck Goliath. Had the Directive gone

through in its proposed form, around 5000 vitamin and mineral

supplement products that people take for natural and preventative

healthcare would have disappeared from the shelves from 1st August

this year. And who in their right minds would have really wanted that?

 

Commenting on the verdict, Dr Robert Verkerk, Executive Director of

ANH said: " This is a fantastic day for the Alliance, the greatest in

its short history. All we have ever wanted is for regulation in

natural health to be based on good science and good law. ANH is now

ready and willing to place its professional expertise and skills in

nutrition and science at the disposal of the EU to make sure that the

same mistakes are not made again. This is not a reprieve – this is a

real result for the consumer and for common sense. "

 

Legal Director and Solicitor David Hinde added: " I would like to thank

our external legal team; our barristers were led by Paul Lasok QC, and

solicitors were led by Jonathan Coad. Many people voiced concerns from

the outset over the implications of the Food Supplements Directive,

but ANH remained committed to working hard at the only means that

would deliver a successful outcome – a professional legal challenge.

This result is a victory for natural healthcare and a landmark legal

precedent for EU law. "

 

The controversial Food Supplements Directive passed through the

European Parliament with a narrow margin of support in early 2002. Its

purpose was ostensibly to harmonize regulation across Europe and

thereby benefit trade. As often happens with EU legislation, most

people are unaware of it until it is too late. ANH was formed in 2002

specifically to oppose punitive legislation affecting natural health

worldwide and has campaigned for three years to have the irrational

parts of the Food Supplements Directive amended. First in January

2004, ANH won the right in the UK High Court to mount the challenge.

This was followed by the hearing in the European Court in January 2005

and then by the Opinion of the ECJ Advocate General on 5 April this

year, when he declared that the Directive was 'invalid under EU law'

and that key aspects of the legislation were 'as transparent as a

black box'. And now, ANH has successfully contested the Food

Supplements Directive in a landmark legal case.

 

From the outset, ANH vigorously promoted the concept of mounting the

legal challenge and has worked 'at the coal face' in Brussels,

Strasbourg and Luxembourg, using the best EU lawyers. ANH's approach

is based on the use of good science and good law in order to shape

appropriate and proportionate regulation of the natural health

industry. It is not an emotions-driven campaign organization. ANH is

based in the UK, but is now a worldwide organization.

 

Drawing its support from thousands of consumers, manufacturers,

retailers, practitioners and some of the world's leading experts in

nutritional medicine, ANH has taken on the Goliath of the European

Commission and those who support the unscientific and unlawful ban of

vitamin and mineral supplements, to protect the interests of everyone

concerned with the leading-edge of food supplements and natural

healthcare.

 

There is concern from some quarters that without the Directive, food

supplements will not always be safe. This is not true as existing UK

and EU food law already provides perfectly effective protection from

unsafe products getting onto the market through existing,

comprehensive food laws. Indeed, ANH firmly endorses the banning of

ingredients or dosages that are patently not safe. It adds however,

that it is not scientifically rational to classify an ingredient as

being unsafe without taking dosage levels into account, something that

was not a condition of being admitted onto the Positive List in the

Food Supplements Directive.

 

The system proposed by the EU was going to ban ingredients simply

because supplement companies did not have the financial capacity to

meet the high data threshold required for the scientific dossiers

demanded by EU authorities. In this way, ingredients that have been

part of the human diet for thousands of years, and which are

increasingly difficult to derive from conventional foods, would be

lost, and would not be able to be supplemented.

 

The effect of today's ruling will avoid these prohibitive costs having

to be incurred because if a vitamin and mineral in a food supplement

is normally found in and consumed as part of the diet it cannot be

banned under the Directive on 1st August 2005 (paragraph 135).

 

This is just the beginning for the Alliance for Natural Health.

Through a United Nations sponsored organization, the Codex

Alimentarius Commission, there are many other regulatory and industry

pressures on natural health. Without having to justify any health

hazard, and without considering any benefits, safety is being used as

a reason to restrict the availability of natural food products and

maximum dosages to ludicrously low levels. The victory with the Food

Supplements Directive is encouraging, but the fight goes on. There are

many opponents to those who support the right to natural health and

much work remains ahead here in the EU and in the US.

 

There are many ways in which ordinary people can help – such as

" adopting a health store. " More information can be found on the ANH

web site, www.alliance-natural-health.org.

TESTIMONIAL: RECOVERY FROM " BIPOLAR DISORDER "

 

In the spring of 2002, I began drinking coffee for the first time in

my life. At the time I was 32 and in excellent physical and mental

health. But as I gradually upped my intake to 2-3 cups of coffee a

day, I began experiencing anxiety and panic attacks, euphoria, and

eventually delusions and paranoia. Although I'd traveled all over the

world, sometimes I was so disoriented I couldn't find my way home from

work. All these symptoms occurred within months of pouring that first

cup of coffee.

 

Worst of all, as my brain function deteriorated I became less aware

that there was anything wrong with me. Clinically speaking, I'd

descended into psychosis.

 

I was diagnosed as bipolar, which came as an enormous relief. But

while researching alternatives to the drugs I was prescribed (since

I'd rarely taken as much as an aspirin for anything), I stumbled

across a link to a site on caffeine toxicity, which mimics bipolar

disorder, schizophrenia and other organic illnesses. Reading the list

of symptoms was like looking into a mirror. I immediately withdrew

from caffeine, and my former health returned--without medication.

 

What troubles me is that shortly after I made the coffee connection, I

showed a hospital psychiatrist the studies I'd found and was dismissed

out of hand. I was a classic case of caffeine intoxication, even as

outlined in the DSM-IV, yet she refused to even look at the studies

and insisted I go on meds. She wasn't uncaring. In fact she was

genuinely concerned for my well-being. But she was completely

blinkered when it came to the possibility of a physical cause of my

symptoms.

 

Since recovering, I've talked to many other " caffeinism " victims whose

health has also returned since they eliminated caffeine from their

diet. But I have to wonder how many more people are being misdiagnosed

with mental illnesses when physical causes are to blame. Two weeks

before I quit caffeine, I was lapsing into states in which my eyes

glazed over, I murmured nonsense to myself, and I walked around like a

zombie, with my arms stiff at my sides. No doctor saw me in this

condition, but I'm certain that if they had I would have been

diagnosed with something more dramatic than bipolar disorder. I have

no doubt that I would have been medicated and, as one caffeinism study

puts it, " lost in a dark, disturbed world, until death. "

 

I've created www.CaffeineWeb.com to alert medical professionals and

caffeinism victims to the symptoms of this easily misdiagnosed

illness, with the hope of sparing others its nightmarish symptoms.

 

Brian Matthews

FDA TO REVIEW ADULT SSRI USE AND SUICIDALITY

 

In response to recent reports in scientific publications regarding

increased risk of suicidal behavior in adults treated with

antidepressants, the FDA announced on July 1, 2005, that it is

convening an advisory committee to assess the risk of suicidality in

adults using SSRIs.

 

The Agency has asked manufacturers to provide information from their

trials using an approach similar to that used in the evaluation of the

risk of suicidal behavior in the pediatric population taking

antidepressants. The review will involve hundreds of clinical trials

and may take more than a year to complete.

 

Following extensive hearings and the recommendation by the FDA's

Psychopharmacologic Drugs & Pediatric Advisory Committees in September

2004, many such drugs now carry a black box warning and other language

concerning the risk of pediatric suicidality, but this will be the

first review for adult users of the drugs.

 

The outcome would have implications on most of the major

antidepressant products, including Forests Lexapro, Celexa and

generics; Glaxo Smith Kline's Paxil CR and Paxil generics; Lilly's

Symbyax and Prozac generics; Pfizer's Zoloft; Organon's Remeron; and

generic versions of Bristol-Myers Squibb's Serzone. It may also impact

the two approved serotonin and norepinephrine reuptake inhibitors:

Lilly's Cymbalta and Wyeth's Effexor.

 

The Public Health Advisory has issued an alert to health-care

providers and patients regarding these drugs. The alert is available at

http://www.fda.gov/cder/drug/advisory/SSRI200507.htm.

MENTAL DECLINE IN ELDERLY LINKED TO POOR VISION

 

A study published in the Journal of the American Geriatric Society,

April 2005, found that impaired near vision correlated with nearly

double the decline in mental acuity.

 

The study, conducted in five southwestern states by the Division of

Geriatric Medicine, Sealy Center on Aging, University of Texas Medical

Branch, followed 2,140 Mexican Americans aged 65 and older for a

period of 7 years. Its purpose was to estimate the association between

sensory impairment and cognitive decline.

 

The participants were examined using standard tests for mental

function at the beginning of the study, and at 2, 5, and 7 years of

follow up. Vision testing was also conducted to determine if there

were impairments in their corrected vision. In the tests for near

vision, they were asked to read numbers from a card while wearing

glasses or contact lenses.

 

Other variables included distance vision, hearing, demographics (age,

sex, marital status, living arrangements, and education), depressive

symptoms, hypertension, diabetes mellitus, stroke, heart attack, and

functional status.

 

Results showed that patients with near vision problems showed a rate

of decline in mental functionality nearly twice that of their peers.

 

The conclusion was that near vision impairment, but not distance

vision or hearing impairments, was associated with cognitive decline

in older Mexican Americans.

 

Attendees of Safe Harbor's recent Non-Pharma IV Conference and heard

Dr. Herbert Solomon's lecture on the role of visual impairment in

mental function, would not be surprised by these findings.

SENATE COMMITTEE ASKS DRUG COMPANIES TO EXPLAIN USE OF GRANTS TO

PROMOTE DRUGS

 

Washington - Sens. Chuck Grassley and Max Baucus have asked a number

of large drug makers to explain a marketing practice where the

companies give money to state governments and other organizations in

the form of grants. The drug companies call the awards " educational

grants " , but the senators are concerned that the dollars are more

focused on product promotion than education.

 

The senators said they want to know more about the practice to ensure

that it's not just a " backdoor way to funnel money to doctors and

other individuals who can influence prescribing and purchasing of

particular prescription medicines, including off-label prescriptions. "

They said their inquiry of the drug manufacturers is based on reports

that some companies have awarded these grants to health care providers

as inducements to those providers to prescribe medications the

companies produce. In other cases, such grants to state agencies may

have prompted those agencies to develop programs leading to

over-medication of patients at the expense of patient health or to

unnecessary expense for taxpayers.

 

" We need to know how this behind-the-scenes funneling of money is

influencing decision makers, " Grassley said. " The decisions result in

the government spending billions of dollars on drugs. The tactics look

aggressive, and the response on behalf of the public needs to be just

as vigorous.

 

" I support drug companies giving back to the community through grants

for educational programs used to educate state governments and health

organizations about products that could lead to improved health, "

Baucus said. " However, I am concerned that some grants may be for

purposes other than education. These grants need to be driven by good

intentions instead of motivation for larger profits. "

 

Grassley is chairman and Baucus is ranking member of the Senate

Committee on Finance, which has legislative and oversight

responsibility for the Medicare and Medicaid programs. The first-ever

prescription drug program within Medicare will begin in January, and

federal expenditures on prescription drugs through both Medicare and

Medicaid are estimated to reach $100 billion in 2006.

 

The letter was sent to the following drug manufacturers:

 

Pfizer, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc.,

AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation, Amgen, Inc., Wyeth Pharmaceuticals, Eli

Lilly & Company, Sanofi Aventis, Eisai, Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Schering-Plough Corporation, Hoffman-LaRoche,

Inc., Forest Pharmaceuticals, Inc., Abbott Laboratories, Genentech,

Inc., Biogen Idec Inc., Genzyme Corporation, Chiron Corporation,

Serono, Inc., and TAP Pharmaceutical Products, Inc.

RETHINKING ILLNESS SYMPTOMS AND TREATMENTS IN MODERN SOCIETY

 

Jeffrey A. Chiacchieri suffered from Chronic Fatigue Syndrome and

depression for 15 years. He is now well. To help others, he has

written a guide that details how he overcame his illnesses, and has

donated it to several charitable institutions. Here is his brief

introduction, and a chapter summary.

 

" For many years my life had become a series of failed attempts to

conquer CFS and severe depression. At one time nobody, including

myself, would have thought that I would not only figure out the

problem, but write a guide on it. This guide describes and details how

I overcame Chronic Fatigue Syndrome and severe depression. It is

dedicated to the untold numbers of people who for too long have been

neglected by conventional healthcare. I have written it as an

educational tool to assist anyone in dealing with unexplainable

symptoms, depression, CFS and other illnesses. "

 

Part 1: How I remain healthy in our toxic environment Part 2: Whole

vitamins vs. synthetic vitamins = politics Part 3: E.M.F. emissions

and avoidance Part 4: The business of symptom suppression Part 5:

Seeing and hearing in a blind and deaf world of medicine Part 6: The

role of government Part 7: Letters and correspondences

 

Read one man's story of how he improved his symptoms at:

 

http://www.nnmh.ca/Member_Submissions/A_guide_in_illness_prevention_+_%20unconve\

ntional_treatment_updated.pdf

FDA TO CHANGE LABELS ON " ADHD " DRUGS

 

The Food and Drug Administration announced on June 28th that it

intends to make labeling changes for drugs used to treat attention

deficit hyperactivity disorder (ADHD). The changes are prompted by

concerns about psychiatric events associated with the drugs.

 

Reports of events such as visual hallucinations, suicidal ideation,

psychotic behavior, aggression and violent behavior will be reviewed

and discussed by a panel of outside medical experts. These reports are

mandated by law for drugs approved for use in children - although the

drugs are also used by adults.

 

It is not yet known how many of these reports exist.

 

The drugs involved are methylphenidate products such as Johnson &

Johnson's Concerta, and Novartis AG's Ritalin as well as it's

generics. Although the agency is also investigating atomexetine, a

nonstimulant product sold as Strattera by Eli Lilly and Co., and

Adderall from Shire Pharmaceutical PLC.

 

" In addition we believe it is critical to examine the other stimulant

products approved for ADHD...to determine if they too are associated

with these adverse events, " the FDA said in its statement.

 

The FDA has asked the panel what information it should provide to the

public about the ADHD drugs while it's collecting the events reports

to be reviewed.

 

The agency is also concerned with reports of cardiovascular events

associated with these drugs. Earlier this year Health Canada ordered

Adderall off the market after reports of sudden death in 20 patients,

including 12 reports of stroke. Adderall's U.S. label was changed in

2004 to warn against the drug's use in children and adults with

structural cardiac abnormalities.

 

The FDA said that it is " pursuing additional means to better

characterize the cardiovascular risks for all drug products approved

for ADHD. "

 

Did someone forward this ezine to you? You can SUBSCRIBE and receive

your own copy of the Alternative Mental Health News directly.

 

Use the sign-up form at AlternativeMentalHealth.com.

 

You can also e-mail your request to ezine?

subject=SUBSCRIBE

 

or contact us in any of the ways listed in this newsletter.

 

Complete UNSUBSCRIBING information is located at the end of this e-mail.

 

All PAST ISSUES of the Alternative Mental Health News are available at

AlternativeMentalHealth.com.

 

Safe Harbor was founded in 1998 in the wake of growing public

dissatisfaction with the unwanted effects of orthodox psychiatric

treatments such as medication and shock therapy.

 

Seeking to satisfy the desire for safer, more effective treatments,

Safe Harbor is dedicated to educating the public, the medical

profession, and government officials on research and treatments that,

minimally, do no harm and, optimally, cure the causes of severe mental

symptoms. Our primary thrust is education on the medical causes of

severe mental symptoms and the use of nutritional and other natural

treatments.

About AlternativeMental

Health.com

 

ALTERNATIVEMENTALHEALTH.COM is the world's largest website devoted

exclusively to alternative mental health treatments. It includes a

directory of over 300 physicians, nutritionists, experts,

organizations, and facilities around the U.S. that offer or promote

safe, alternative treatments for severe mental symptoms. Many of the

physicians listed do in-depth examinations to find the physical causes

behind mental problems.

 

Also included on the site is an array of articles on topics ranging

from the medical causes of schizophrenia to the effects of toxic

metals on mental health.

 

Special AlternativeMentalHealth.com T-shirts and bumper stickers are

available at our online store.

 

A bookstore page lists top books that cover many areas of alternative

treatments with titles like Natural Healing for Schizophrenia and

Other Common Mental Disorders and No More Ritalin.

 

AlternativeMentalHealth.com has been created to educate the public,

practitioners, and government officials on the medical conditions that

create " mental illness " and the many safe resources available for

addressing and often curing severe mental symptoms.

Contact Us

 

Safe Harbor

 

787 W. Woodbury Rd., #2

 

Altadena, CA 91001

 

Phone: 626-791-7868

 

Fax: 626-791-7869

 

SafeHarborProj

 

AlternativeMentalHealth.com

 

Safe Harbor Boston

 

Gary Shapiro, President

 

Post Office Box 218

 

Newton, MA 02468 U.S.A.

 

Phone: 617-964-5544 SafeHarborB

 

Safe Harbor Maryland

 

Margo Duesterhaus, President

 

410-480-5498 or

 

margo@

 

alternativementalhealth.com

 

Safe Harbor New Mexico

 

Louisa Putnam, President

 

505 988-4242 or

 

louisa_putnam

 

Safe Harbor Oklahoma

 

Sandra Lykins, President

 

8177 S. Harvard # 826

 

Tulsa, Oklahoma 74137

 

Email: Okalternativementalhealth@

 

 

phone: 918-271-2327

 

Safe Harbor India

 

Bhargavi Davar, PhD, President

 

B-1, 11/12 Konak Pooram

 

Kondhwa

 

Pune, India 411 048

 

(0091) 020-26837644 or

 

wamhc

 

Safe Harbor Oman

 

Aziz Alnamani, MD, President

 

Box 192 P.C. 122

 

Muscat

 

Sultanate of Oman

 

Phone: (968) 99292979

 

Fax: (968) 24493417

 

Email: topmedics

 

 

 

We welcome your donations. As a nonprofit organization, Safe Harbor is

supported solely through the generosity of the public. Donations can

be made online at our web site or mailed to the above address. We also

accept Visa/ MasterCard by phone. Thank you.